Utilizzo del protocollo dietetico multifasico (Dietacare® Named) in donne lavoratrici e sua efficacia nel trattamento del sovrappeso-obesità correlati alla sindrome metabolica

Translated title of the contribution: A multiphase dietetic protocol (Dietacare® Named): efficacy for the treatment of overweight/obesity related to the metabolic syndrome in female workers

L. Vigna, C. E. Barberi, A. S. Tirelli, D. Sommaruga, L. Riboldi

Research output: Contribution to journalArticle

Abstract

The need to maintain a proper weight control, avoiding to exceed risk levels associated to the development of clinical complications related to obesity and overweight, such as the metabolic syndrome, becomes critical also in the workplace. The use of a dietetic protocol which includes a high-protein, very-low calorie diet (VLCD), under strict medical supervision, seems to represent an effective approach to achieve a prompt weight loss in most obesity/overweight typologies, and in particular in subjects who struggle to lose weight with traditional diets. Objective: The purpose of this study was to evaluate feasibility, safety and efficacy of a multiphase dietetic protocol (Dietacare® Named) combined with nutritional supplement, in weight loss as well as in lowering/attenuation of cardio-methabolic risk in a group of female workers affected by obesityoverweight and metabolic syndrome. Materials and Methods: Twelve overweight/obese female workers (mean age 47.14 ± 10.26 years; mean BMI 5.39 ± 5.26), have been assessed for variations of anthropometric variables (waist circumference, weight, BMI), hematologic parameters associated with metabolic syndrome (triglycerides, HDL cholesterol, fasting glycaemia), arterial blood pressure, and body composition (assessed with an InBody230 Wunder bioelectrical impedance analyzer) before and after administering of a multiphase dietetic protocol (Dietacare ® Named) for 8 weeks. Results: The observed clinically meaningful decrease of body weight (96.43 ± 15.7 kg vs 87.89 ± 14.5 kg; -8.85% of the basal body weight) was primarily associated to a reduction of the fat body mass (-19.89 ± 8.31%) and of the waist circumference (-8.22 ± 4.17%), with improvement in hematologic parameters such as triglycerides (-20.59 ± 13.62%) and fasting glycaemia. Lean body mass (-1.69 ± 4.02%) as well as the muscular mass (-2.85 ± 3.96%) have been only minimally affected. Conclusions: The observed mean decrease of body weight and the variation of body composition with preservation of metabolically active tissue of lean body mass, most likely due to the protein daily supply of 1.0 ± 0.2 g per kg of ideal body weight, suggest that VLCD is safe. The results of this study show that the multiphase dietetic program utilized has been effective in producing a weight loss and in improving the clinical conditions of overweight/obese female workers affected by metabolic syndrome.

Original languageItalian
Pages (from-to)116-125
Number of pages10
JournalProgress in Nutrition
Volume15
Issue number2
Publication statusPublished - 2013

    Fingerprint

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this